Article
Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
Clinical nuclear medicine - 1 Mar 2015
Lee Elaine Yuen Phin, Khong Pek-Lan, Lee Victor Ho Fun, Qian Wenshu, Yu Xue, Wong Maria Pik
Abstract excerpt
PURPOSE: Epidermal growth factor receptor (EGFR) mutation status is important in treatment stratification of stage IV lung adenocarcinoma. We evaluated the relationship between the SUV max measured on PET/CT and EGFR mutations and the value of SUV max in predicting EGFR mutations. PATIENTS AND METHODS: Seventy-one stage IV lung adenocarcinoma patients with verified EGFR mutations (48 EGFR mutant, 23 EGFR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
